These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 16314073)

  • 1. A knock-in mouse model of congenital erythropoietic porphyria.
    Ged C; Mendez M; Robert E; Lalanne M; Lamrissi-Garcia I; Costet P; Daniel JY; Dubus P; Mazurier F; Moreau-Gaudry F; de Verneuil H
    Genomics; 2006 Jan; 87(1):84-92. PubMed ID: 16314073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congenital erythropoietic porphyria: prolonged high-level expression and correction of the heme biosynthetic defect by retroviral-mediated gene transfer into porphyric and erythroid cells.
    Kauppinen R; Glass IA; Aizencang G; Astrin KH; Atweh GF; Desnick RJ
    Mol Genet Metab; 1998 Sep; 65(1):10-7. PubMed ID: 9787090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling of congenital erythropoietic porphyria by RNA interference: a new tool for preclinical gene therapy evaluation.
    Robert-Richard E; Lalanne M; Lamrissi-Garcia I; Guyonnet-Duperat V; Richard E; Pitard V; Mazurier F; Moreau-Gaudry F; Ged C; de Verneuil H
    J Gene Med; 2010 Aug; 12(8):637-46. PubMed ID: 20586119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Successful gene therapy of mice with congenital erythropoietic porphyria].
    de Verneuil H; Robert-Richard E; Ged C; Mazurier F; Richard E; Moreau-Gaudry F
    Med Sci (Paris); 2008; 24(6-7):615-20. PubMed ID: 18601879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction of deficient CD34+ cells from peripheral blood after mobilization in a patient with congenital erythropoietic porphyria.
    Mazurier F; Géronimi F; Lamrissi-Garcia I; Morel C; Richard E; Ged C; Fontanellas A; Moreau-Gaudry F; Morey M; de Verneuil H
    Mol Ther; 2001 Mar; 3(3):411-7. PubMed ID: 11273784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of proteasome inhibitors in congenital erythropoietic porphyria.
    Blouin JM; Duchartre Y; Costet P; Lalanne M; Ged C; Lain A; Millet O; de Verneuil H; Richard E
    Proc Natl Acad Sci U S A; 2013 Nov; 110(45):18238-43. PubMed ID: 24145442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of congenital erythropoietic porphyria using matched unrelated hematopoietic stem cell transplantation.
    Martinez Peinado C; Díaz de Heredia C; To-Figueras J; Arias-Santiago S; Nogueras P; Elorza I; Olivé T; Bádenas C; Moreno MJ; Tercedor J; Herrero C
    Pediatr Dermatol; 2013; 30(4):484-9. PubMed ID: 23557135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A molecular study of congenital erythropoietic porphyria in cattle.
    Agerholm JS; Thulstrup PW; Bjerrum MJ; Bendixen C; Jørgensen CB; Fredholm M
    Anim Genet; 2012 Apr; 43(2):210-5. PubMed ID: 22404357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective gene therapy of mice with congenital erythropoietic porphyria is facilitated by a survival advantage of corrected erythroid cells.
    Robert-Richard E; Moreau-Gaudry F; Lalanne M; Lamrissi-Garcia I; Cario-André M; Guyonnet-Dupérat V; Taine L; Ged C; de Verneuil H
    Am J Hum Genet; 2008 Jan; 82(1):113-24. PubMed ID: 18179890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital erythropoietic porphyria.
    To-Figueras J; Erwin AL; Aguilera P; Millet O; Desnick RJ
    Liver Int; 2024 Aug; 44(8):1842-1855. PubMed ID: 38717058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetics of congenital erythropoietic porphyria.
    Desnick RJ; Glass IA; Xu W; Solis C; Astrin KH
    Semin Liver Dis; 1998; 18(1):77-84. PubMed ID: 9516681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two brothers with mild congenital erythropoietic porphyria due to a novel genotype.
    Berry AA; Desnick RJ; Astrin KH; Shabbeer J; Lucky AW; Lim HW
    Arch Dermatol; 2005 Dec; 141(12):1575-9. PubMed ID: 16365260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Missense UROS mutations causing congenital erythropoietic porphyria reduce UROS homeostasis that can be rescued by proteasome inhibition.
    Blouin JM; Bernardo-Seisdedos G; Sasso E; Esteve J; Ged C; Lalanne M; Sanz-Parra A; Urquiza P; de Verneuil H; Millet O; Richard E
    Hum Mol Genet; 2017 Apr; 26(8):1565-1576. PubMed ID: 28334762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uroporphyrinogen III synthase knock-in mice have the human congenital erythropoietic porphyria phenotype, including the characteristic light-induced cutaneous lesions.
    Bishop DF; Johansson A; Phelps R; Shady AA; Ramirez MC; Yasuda M; Caro A; Desnick RJ
    Am J Hum Genet; 2006 Apr; 78(4):645-58. PubMed ID: 16532394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of congenital erythropoietic porphyria in children by allogeneic stem cell transplantation: a case report and review of the literature.
    Shaw PH; Mancini AJ; McConnell JP; Brown D; Kletzel M
    Bone Marrow Transplant; 2001 Jan; 27(1):101-5. PubMed ID: 11244446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C73R is a hotspot mutation in the uroporphyrinogen III synthase gene in congenital erythropoietic porphyria.
    Frank J; Wang X; Lam HM; Aita VM; Jugert FK; Goerz G; Merk HF; Poh-Fitzpatrick MB; Christiano AM
    Ann Hum Genet; 1998 May; 62(Pt 3):225-30. PubMed ID: 9803266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ALAS2 acts as a modifier gene in patients with congenital erythropoietic porphyria.
    To-Figueras J; Ducamp S; Clayton J; Badenas C; Delaby C; Ged C; Lyoumi S; Gouya L; de Verneuil H; Beaumont C; Ferreira GC; Deybach JC; Herrero C; Puy H
    Blood; 2011 Aug; 118(6):1443-51. PubMed ID: 21653323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feline congenital erythropoietic porphyria: two homozygous UROS missense mutations cause the enzyme deficiency and porphyrin accumulation.
    Clavero S; Bishop DF; Giger U; Haskins ME; Desnick RJ
    Mol Med; 2010; 16(9-10):381-8. PubMed ID: 20485863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uroporphyrinogen III synthase mutations related to congenital erythropoietic porphyria identify a key helix for protein stability.
    Fortian A; Castaño D; Ortega G; Laín A; Pons M; Millet O
    Biochemistry; 2009 Jan; 48(2):454-61. PubMed ID: 19099412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational analysis of uroporphyrinogen III cosynthase gene in Iranian families with congenital erythropoietic porphyria.
    Moghbeli M; Maleknejad M; Arabi A; Abbaszadegan MR
    Mol Biol Rep; 2012 Jun; 39(6):6731-5. PubMed ID: 22350154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.